Defining prostate cancer size and treatment margin for focal therapy: does intralesional heterogeneity impact the performance of multiparametric MRI?

Edwin Jonathan AslimYu Xi Terence LawStephanie Man Chung Fook-ChongHenry Sun Sien HoJohn Shyi Peng YuenWeber Kam On LauLui Shiong LeeChristopher Wai Sam ChengNye Thane NgoYan Mee LawKae Jack Tay

Published in: BJU international (2021)

Multiparametric MRI performance in estimating prostate cancer size, and consequently the treatment margin for FT, is impacted by tumour size and the intralesional heterogeneity of cancer grades.

Keyphrases

prostate cancer
radical prostatectomy
magnetic resonance imaging
contrast enhanced
single cell
stem cells